Hsiu Mei Huang
Director/Miembro de la Junta en TaiGen Biotechnology Co., Ltd. .
Perfil
Hsiu Mei Huang is an Independent Director at TaiGen Biotechnology Co., Ltd.
She previously served as an Independent Director at Taiwan Liposome Co., Ltd.
and TWi Pharmaceuticals, Inc. She also held positions as Managing Director at Glaxosmithkline and General Manager & Spokesman at OBI Pharma, Inc. Huang received her undergraduate degree from National Taiwan University.
Cargos activos de Hsiu Mei Huang
| Empresas | Cargo | Inicio |
|---|---|---|
TaiGen Biotechnology Co., Ltd.
 TaiGen Biotechnology Co., Ltd. Pharmaceuticals: MajorHealth Technology TaiGen Biotechnology Co., Ltd. is a research-based and product-driven pharmaceutical company engaging in the development of therapeutics for infectious diseases, cancer, and diabetes-related complications. Its activities include drug discovery, development, global regulatory, and commercialization in China. The company was founded by Ming-Chu Hsu in 2001 and is headquartered in Taipei, Taiwan. | Director/Miembro de la Junta | - |
Antiguos cargos conocidos de Hsiu Mei Huang.
| Empresas | Cargo | Fin |
|---|---|---|
| Glaxosmithkline /Taiwan/ | Corporate Officer/Principal | - |
| OBI PHARMA, INC. | Director Ejecutivo | - |
| TWI PHARMACEUTICALS INC | Director/Miembro de la Junta | - |
| TAIWAN LIPOSOME COMPANY, LTD. | Director/Miembro de la Junta | - |
Formación de Hsiu Mei Huang.
| National Taiwan University | Undergraduate Degree |
Experiencias
Funciones ocupadas
Activas
Inactivas
Empresas cotizadas
Empresas privadas
Relaciones
Relaciones de 1er grado
Empresas vinculadas al 1er grado
Hombre
Mujer
Administradores
Ejecutivos
Empresas relacionadas
| Empresas cotizadas | 1 |
|---|---|
| OBI PHARMA, INC. | Health Technology |
| Empresas privadas | 4 |
|---|---|
TaiGen Biotechnology Co., Ltd.
TaiGen Biotechnology Co., Ltd. Pharmaceuticals: MajorHealth Technology TaiGen Biotechnology Co., Ltd. is a research-based and product-driven pharmaceutical company engaging in the development of therapeutics for infectious diseases, cancer, and diabetes-related complications. Its activities include drug discovery, development, global regulatory, and commercialization in China. The company was founded by Ming-Chu Hsu in 2001 and is headquartered in Taipei, Taiwan. | Health Technology |
Taiwan Liposome Co., Ltd.
 Taiwan Liposome Co., Ltd. Pharmaceuticals: MajorHealth Technology Taiwan Liposome Co., Ltd. engages in the research and development of lipid-based formulation drugs. Its products are used for pain management, eye disease treatment, and cancer treatment. The company was founded by Kee Lung Hong on November 10, 1997 and is headquartered in Taipei, Taiwan. | Health Technology |
TWi Pharmaceuticals, Inc.
 TWi Pharmaceuticals, Inc. Pharmaceuticals: MajorHealth Technology TWi Pharmaceuticals, Inc. operates as a technology-based special pharmaceutical company. The firm engages in the development and commercialization of high barrier generics drugs. Its products include donepezil hydrochloride tablets, megestrol acetate oral suspension, hydroquinone cream, guanfacine extended-release tablets and nifedipine extended-release tablets. The company was founded by Chih Ming Chen on December 1, 1997 and is headquartered in Taipei, Taiwan. | Health Technology |
| Glaxosmithkline /Taiwan/ |
- Bolsa de valores
- Insiders
- Hsiu Mei Huang
